Tuesday's Morning Movers: FXCM Takes Another Big Drop

By: via Benzinga
IsoRay, Inc. (NYSE: ISR) +18% - University of Pittsburgh School of Medicine reports that IsoRay’s Cesium-131 Prostate Treatment ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.